Translating Aging
Translating Aging
Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis, Moonwalk Biosciences)
Loading
/

Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis, Moonwalk Biosciences)

Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss Moonwalk's innovative approach to developing a new class of medicines aimed at treating complex diseases and potentially extending human healthspan.

The Finer Details:

  • The concept of epigenetics as the "source code" for cell states
  • Moonwalk's technology for analyzing and modifying the epigenome
  • The company's focus on cardiometabolic diseases and adiposity
  • Comparison of Moonwalk's approach to other epigenetic reprogramming strategies
  • Potential applications in treating obesity and metabolic disorders
  • The use of AI and machine learning in epigenetic research
  • Future directions and challenges for Moonwalk Biosciences

Quotes:

Quotes have been lightly edited for clarity.

"In the past, I've heard people refer to the DNA as the blueprint of biology, and I don't quite like that analogy. I think of it as more like the hardware, and the epigenome is the source code —the epigenome is responsible for the complex coordination of different genes that lead to proteins, and the temporal aspects of those so it's really how the hardware is used to make and maintain and change different cell types."

"We're opening up the epigenome as a platform for drug discovery. The vast majority of the genome is not the coding regions, but it's incredibly important in controlling gene expression. So there's a lot of biology in there to inform our selection of targets, and we think that could dramatically improve both the number of interesting targets and our ability to select targets. The data that we're creating, our expertise, and our computational tools make us amongst the best in the world at using the epigenome for drug discovery."

Links:

Email questions, comments, and feedback to: podcast@biohagelabs.com

Translating Aging on Twitter: @bioagepodcast

BioAge website: https://bioagelabs.com

BioAge Twitter: [@bioagelabs]

More From Current Show

Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new...
Listen Now
Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that...
Listen Now
Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital...
Listen Now
In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay...
Listen Now
Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to...
Listen Now
Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with...
Listen Now
Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions...
Listen Now
Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life...
Listen Now

Related Episodes

No related episodes found.